CINECA IRIS Institutional Research Information System

LUCCHI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.765
EU - Europa 5.089
AS - Asia 1.816
AF - Africa 226
SA - Sud America 15
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 8
Totale 18.930
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.478
IT - Italia 1.777
SE - Svezia 889
DE - Germania 877
CN - Cina 824
BG - Bulgaria 543
SG - Singapore 380
CA - Canada 283
UA - Ucraina 236
GB - Regno Unito 220
VN - Vietnam 211
TR - Turchia 181
FI - Finlandia 143
CI - Costa d'Avorio 140
AT - Austria 102
IN - India 94
RU - Federazione Russa 67
HK - Hong Kong 63
CH - Svizzera 62
FR - Francia 60
SN - Senegal 53
BE - Belgio 33
NG - Nigeria 20
IR - Iran 11
NL - Olanda 11
IE - Irlanda 10
BR - Brasile 9
EG - Egitto 9
PL - Polonia 9
RO - Romania 8
AU - Australia 7
DK - Danimarca 7
EU - Europa 7
KR - Corea 7
CZ - Repubblica Ceca 6
ES - Italia 6
ID - Indonesia 6
PT - Portogallo 6
RS - Serbia 6
JP - Giappone 5
SA - Arabia Saudita 5
CO - Colombia 4
JO - Giordania 4
MX - Messico 4
NZ - Nuova Zelanda 4
AL - Albania 3
BJ - Benin 3
IL - Israele 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
MY - Malesia 3
PK - Pakistan 3
GR - Grecia 2
LU - Lussemburgo 2
OM - Oman 2
TW - Taiwan 2
AM - Armenia 1
AR - Argentina 1
BY - Bielorussia 1
DZ - Algeria 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
IQ - Iraq 1
NO - Norvegia 1
PH - Filippine 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 18.930
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.558
Fairfield 1.448
Houston 1.108
Chandler 958
Ann Arbor 813
Ashburn 723
Seattle 611
Sofia 542
Cambridge 532
Wilmington 497
New York 342
Beijing 331
Milan 316
Boardman 280
Ottawa 273
Princeton 238
Jacksonville 228
Lawrence 221
Pisa 214
Florence 200
Medford 195
Serra 169
Izmir 167
Nanjing 157
Des Moines 147
Abidjan 140
Singapore 127
Vicopisano 126
Vienna 99
San Diego 89
Frankfurt am Main 86
Dearborn 85
Bremen 67
Boulder 63
Nanchang 62
Bern 59
Dong Ket 58
Hong Kong 57
Ogden 56
Dakar 53
Kunming 43
Pune 39
Jüchen 38
Lancaster 36
Falls Church 35
Rome 34
Brussels 32
Los Angeles 31
Redwood City 29
London 28
Shenyang 26
Tianjin 26
Jiaxing 24
Hebei 23
Lucca 23
Hefei 22
Lagos 20
Norwalk 20
Livorno 19
Changsha 18
Turin 15
Auburn Hills 14
Phoenix 14
Washington 13
Dallas 12
Hangzhou 12
Marseille 12
Nürnberg 12
Munich 11
Jinan 10
Orange 10
New Delhi 9
Seacroft 9
Cascina 8
Dublin 8
Guangzhou 7
San Francisco 7
Warsaw 7
Grafing 6
Hyderabad 6
Indiana 6
Lappeenranta 6
Las Vegas 6
Shanghai 6
Verona 6
Chicago 5
Helsinki 5
Kent 5
Kilburn 5
Massa 5
Redmond 5
Tappahannock 5
Viareggio 5
Belgrade 4
Cairo 4
Changchun 4
Edinburgh 4
Lanzhou 4
Naples 4
Osimo 4
Totale 14.361
Salva come PNG Salva come JPEG
Nome #
null 346
Expression status of candidate genes in mesothelioma tissues and cell lines 235
La densità microvascolare (DMV) come marker prognostico e predittivo nelle neoplasie maligne dell'albero bronchiale in fase avanzata. 220
A common polymorphism within MSLN affects miR-611 binding site and soluble mesothelin levels in healthy people 174
Surgical treatment of pleural recurrence from thymoma 151
Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism 149
Malignant pleural mesothelioma and mesothelial hyperplasia: A new molecular tool for the differential diagnosis 147
Second primary lung cancer and relapse: treatment and follow-up. 142
Diaphragm and lung-preserving surgery with hyperthermic chemotherapy for malignant pleural mesothelioma: A 10-year experience 141
Four thymus-related syndromes in a case of invasive thymoma 140
Percutaneous radiofrequency ablation (pRTA) of pulmonary tumors 138
null 138
Advanced stage thymomas and thymic carcinomas: results of multimodality treatments 132
A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma 130
Serum mesothelin, osteopontin and vimentin: useful markers for clinical monitoring of malignant pleural mesothelioma 129
TERMOABLAZIONE DI NEOPLASIE POLMONARI MALIGNE: QUALI PROSPETTIVE 128
Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study 128
EGFR and KRAS mutational analysis in a large series of Italian non-small cell lung cancer patients: 2,387 cases from a single center 128
Whole transcriptome targeted gene quantification provides new insights on pulmonary sarcomatoid carcinomas 125
Distinct Angiogenic microRNA-mRNA Expression Profiles Among Subtypes of Lung Adenocarcinoma. 124
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study 124
null 123
A reappraisal of the indications for laparoscopic treatment of adrenal metastases 123
Let-7g and miR-21 expression in non-small cell lung cancer: correlation with clinicopathological and molecular features 123
Association of the DNMT3B -579G>T polymorphism with risk of thymomas in patients with myasthenia gravis. 123
Resection of single brain metastasis in non-small-cell lung cancer: prognostic factors. 120
210P: Digital gene expression profiling to separate malignant pleural mesothelioma from benign reactive mesothelial hyperplasia 120
Alterations of Fas (APO-1/CD95) gene and its relationship with p53 in non small cell lung cancer 119
null 116
Pre-operative chemotherapy for stage IIIa (N2) non-small cell lung cancer. 115
Surgical treatment of recurrent thymomas 115
Comparison between plasma and serum osteopontin levels: usefulness in diagnosis of epithelial malignant pleural mesothelioma 115
KIF5B/RET fusion gene analysis in a selected series of cytological specimens of EGFR, KRAS and EML4-ALK wild-type adenocarcinomas of the lung 114
null 114
A high vascular count and overexpression of Vascular Endothelial Growth Factor (VEGF) are associated with unfavorable prognosis in operated Small Cell Carcinoma (SCLC) 112
Primary neuroendocrine tumors of the thymus: a multicenter experience of 35 patients. 112
Accumulation of gene protein product P53 correlates with high microvessel count in non small cell lung carcinomas 111
[18F]FDG-PET/CT patterns of bone metastases in lung cancer 111
Disappearance of Anti-Thyroid Autoantibodies following Thymectomy in Patients with Myasthenia Gravis 111
Favourable survival outcome in patients with SCLC treated by sequential intensive chemotherapy and high dose chest irradiation 110
Surgical treatment of non-small cell lung cancer in octogenarians 110
Neoangiogenesis as prognostic indicator of survival in lung cancer. 109
Gastropleural fistula as complication of post-pneumonectomy empyema 108
A strategy for thoracoscopic resection of small pulmonary nodules 108
null 108
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors. 107
Massive pneumoencephalus of late onset after an en-bloc resection for lung cancer 106
Polymer self-locking clips for vascular control during minimally invasive pulmonary lobectomies 106
Surgical treatment of NSCLC in octuagenarians. 106
Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance 106
A gene-expression-based test can outperform bap1 and p16 analyses in the differential diagnosis of pleural mesothelial proliferations. 106
Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study 106
2ND PRIMARY LUNG-CANCER AND RELAPSE - TREATMENT AND FOLLOW-UP 105
Metachronous adrenal masses in resected non-small cell lung cancer patients:therapeutic implications of laparoscopic adrenalectomy 105
Reply to heyman and van schil 103
Identification of Fas (APO-1/CD95) and p53 gene mutations in non-small cell lung cancer 103
Robotic lobectomy for lung cancer: Evolution in technique and technology 103
The thymidylate synthase enhancer region (TSER) polymorphism increases the risk of thymic lymphoid hyperplasia in patients with Myasthenia Gravis 103
Applications of tissue microarray technology in immunohistochemistry: a study on c-kit expression in small cell lung cancer 102
WWOX expression in different histologic types and subtypes of non-small cell lung cancer 102
Robotic extended thymectomy for early-stage thymomas 102
Is left upper lobectomy always worthwhile for early stage lung cancer? A comparison between left upper lobectomy, trisegmentectomy, and lingulectomy 102
Screen-detected multiple primary lung cancers in the ITALUNG trial 102
null 102
Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial 100
Pleural recurrence of thymoma: Surgical resection followed by hyperthermic intrathoracic perfusion chemotherapy 100
Ten-year experience of mediastinal robotic surgery in a single referral centre 98
null 98
Acute major airway injuries: clinical features and management 97
Radio-guided thoracoscopic surgery (RGTS) of small pulmonary nodules. 96
Multimodal lung cancer screening using the ITALUNG Biomarker Panel and Low Dose Computed Tomography. Results of the ITALUNG biomarker study 95
A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma 94
Evaluation of the Incidence and Potential Mechanisms of Tracheal Complications in Patients With COVID-19 94
The multimodality treatment of thymic carcinoma 93
Nerve-Sparing Surgery in Advanced Stage Thymomas 93
Intraoperative sentinel lymph node mapping in stage I non-small cell lung cancer: detection of micrometastases by polymerase chain reaction 92
Alterations of Fas (APO-1/CD95) gene and its relationship with p53 in non small cell lung cancer 92
Chest wall resection for mesothelioma recurrence after surgery 92
ALK rearrangement in a large series of consecutive non-small cell lung cancers: Comparison between a new immunohistochemical approach and fluorescence in situ hybridization for the screening of patients eligible for crizotinib treatment 91
Angiogenesis as a prognostic indicator of survival in non small cell lung carcinoma: a prospective study. 90
Surgical treatment of stage III thymic tumors: a multi-institutional review from four Italian centers 89
Gene-specific methylation analysis in thymomas of patients with myasthenia gravis 89
IIIB-T4 non-small cell lung cancer: indications and results of surgical treatment 88
Expression profiling and microRNA regulation of the LKB1 pathway in young and aged lung adenocarcinoma patients 88
Interleukin-8 in non-small cell lung carcinoma: relation with angiogenic pattern and p53 alterations 88
New Keywords in the Treatment of Malignant Pleural Mesothelioma 87
PTPN22 and myasthenia gravis: Replication in an Italian population and meta-analysis of literature data 85
Video robotic lobectomy 84
Gamma-probe guided thoracoscopic surgery of small pulmonary nodules 84
Intraoperative sentinel lymph node mapping in stage I non-small cell lung cancer: detection of micrometastases by polymerase chain reaction 84
null 83
Thymic carcinoma: a report of 13 cases 83
Association of thymoma and myasthenia gravis: oncological and neurological results of the surgical treatment 83
MIB1 labelling does not affect metastasis and overall survival in non small cell lung carcinomas 81
Prognostic significance of tumoral angiogenesis in completely resected patients with late-stage lung cancer (Stage IIIa-N2). Impact of adjuvant therapies in a subset of patients at high risk of recurrence. 81
Percutaneous radiofrequency ablation of primary NSCLC 80
null 80
Prognostic significance of tumoral angiogenesis in completely resected late stage lung carcinoma (stage IIIA-N2) - Impact of adjuvant therapies in a subset of patients at high risk of recurrence 80
Investigation of GHSR methylation levels in thymomas from patients with Myasthenia Gravis 80
Neoangiogenesis: A putative marker of malignancy in non-small-cell lung cancer (NSCLC) development 79
Totale 11.187
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.538
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.538
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.044 0 0 250 277 428 393 418 316 366 253 268 75
2020/20211.686 147 89 115 70 230 81 101 161 172 125 115 280
2021/20222.660 23 170 97 130 487 371 139 124 165 149 132 673
2022/20233.053 369 375 229 289 307 413 42 219 549 11 221 29
2023/20242.237 199 193 236 269 306 394 120 79 41 40 118 242
2024/2025475 153 302 20 0 0 0 0 0 0 0 0 0
Totale 19.342